Iopidine is a medicine containing the active ingredient(s) apraclonidine. On this page you will find out more about Iopidine, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: apraclonidine
Information for medicine and pack size:
Iopidine 0.5% eye drops solution, 10 mL
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
To control intraocular pressure in glaucoma patients on maximally tolerated glaucoma therapy for a period of 3 months. In clinical studies the drop in intraocular pressure (IOP) appeared to decrease after Day 60 which may be associated with a progression of the disease or loss of effect of the drug. This phenomenon appears to be an individual occurence with a variable time of onset. As with any patient on maximally tolerated therapy (See Dosage & Administration), patients using apraclonidine 0.5% eye drops to delay surgery should have frequent follow-up examinations and treatment should be discontinued if IOP rises significantly. In patients who have maintained a response to apraclonidine 0.5% eye drops for 3 months and a decision is made to continue treatment, safety aspects, including any evidence of corneal changes (see Warnings and Precautions), and IOP control should be closely monitored.
Table of characteristics
|Visual appearance||A clear colourless to pale yellow solution.|
|Dosage Form||Eye Drops, solution|
|Route of administration||Ophthalmic|
1 x 10mL: Prescription Only Medicine, or Prescription Animal Remedy
1 x 2.5mL: Prescription Only Medicine, or Prescription Animal Remedy
1 x 5mL: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||3 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 October 2017
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.